Left Menu
Development News Edition

Science News Roundup: Bristol-Myers reports positive data on cancer treatment acquired in Celgene deal

Reuters | Updated: 09-12-2019 02:30 IST | Created: 09-12-2019 02:26 IST
Science News Roundup: Bristol-Myers reports positive data on cancer treatment acquired in Celgene deal
Image Credit: Flickr

Following is a summary of current science news briefs. Bristol-Myers reports positive data on cancer treatment acquired in Celgene deal

Bristol-Myers Squibb Co on Saturday said that an experimental cancer therapy it acquired as part of its $74 billion deal for Celgene Corp produced positive results in a clinical trial. The company said it will apply for U.S. approval for the treatment for a type of advanced blood cancer by the end of the year. Half of the lymphoma patients alive three years after Gilead cell therapy treatment: study

Nearly half of lymphoma patients treated with Gilead Sciences Inc's Yescarta were alive at least three years after a one-time infusion of the CAR-T cell therapy, according to data presented on Saturday. Out of 101 patients treated with Yescarta for an aggressive blood cancer known as refractory large B-cell lymphoma in the study, 47 were still alive at least three years later, the data presented at the American Society of Hematology meeting in Orlando showed.


TRENDING

OPINION / BLOG / INTERVIEW

Uganda COVID-19 response: Was off to a good start but reopening dwindled prospects

Uganda has shown success in using health information to enhance efficiency of disease surveillance, reporting and monitoring. The success, however, has critical challenges confronting it as the country resumes normal activities....

New farm bills in India: Focusing on farms or farmers?

... ...

Kenya’s COVID-19 response: Chaos amid lack of information

Confusing numbers and scanty information on how effective curfews and lockdowns have been in breaking transmission have amplified coordination and planning challenges in Kenyas response to COVID-19. Without accurate data, it is impossible t...

Farkhad Akhmedov: Calculating the price of impunity from the law

In insistences such as the battle over the Luna, Akhmedov has resorted to extreme legal machinations to subvert the High Courts decision and keep his assets from being seized. ...

Videos

Latest News

Reliance Industries Q2 net falls 15 pc on weak oil business

Billionaire Mukesh Ambanis Reliance Industries Ltd on Friday reported a 15 per cent drop in second quarter net profit after a slump in core oil and chemicals business dragged down continued good showing in consumer-facing verticals such as ...

Bihar Cong leaders meet Guv; seek dismissal of Nitish govt

Bihar Congress leaders met Governor Phagu Chauhan on Friday and demanded dismissal of the Nitish Kumar government in the midst of the ongoing state assembly polls, holding it responsible for the firing in Munger during a Durga Puja event th...

37 pc engineers find stretched working hours most challenging during WFH: Survey

Even as the majority of engineers interviewed favour remote working, 37 per cent them find work from home challenging mostly due to extended working hours, according to a survey. Irrespective of their professional experience, a majority of ...

Pak minister s admission revealed truth of Pulwama attack, silenced govt critics: Rajnath Singh

Defence Minister Rajnath Singh Friday said that a Pakistani ministers admission of his countrys involvement in the 2019 Pulwama attack has revealed the truth on the matter and silenced those who had questioned the NDA governments intent on ...

Give Feedback